Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration
Zahra Razavi,
No information about this author
Seyed Sina Alizadeh,
No information about this author
F. S. Razavi
No information about this author
et al.
International Journal of Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
670, P. 125186 - 125186
Published: Jan. 8, 2025
The
blood-brain
barrier
(BBB)
plays
a
vital
role
in
protecting
the
central
nervous
system
(CNS)
by
preventing
entry
of
harmful
pathogens
from
bloodstream.
However,
this
also
presents
significant
obstacle
when
it
comes
to
delivering
drugs
for
treatment
neurodegenerative
diseases
and
brain
cancer.
Recent
breakthroughs
nanotechnology
have
paved
way
creation
wide
range
nanoparticles
(NPs)
that
can
serve
as
carriers
diagnosis
therapy.
Regarding
their
promising
properties,
organic
NPs
potential
be
used
effective
drug
delivery
across
BBB
based
on
recent
advancements.
These
remarkable
ability
penetrate
using
various
mechanisms.
This
review
offers
comprehensive
examination
intricate
structure
distinct
properties
BBB,
emphasizing
its
crucial
function
preserving
balance
regulating
transport
ions
molecules.
disruption
conditions
such
stroke,
Alzheimer's
disease,
Parkinson's
disease
highlights
importance
developing
creative
approaches
drugs.
Through
encapsulation
therapeutic
molecules
precise
targeting
processes
vasculature,
NP
formulations
present
hopeful
strategy
improve
BBB.
We
explore
changes
pathological
investigate
factors
affect
successful
into
brain.
In
addition,
we
most
systems
associated
with
shown
positive
results
treating
ischemic
disorders.
opens
up
new
possibilities
nanotechnology-based
therapies
cerebral
diseases.
Language: Английский
Inorganic Nanoparticles and Blood-Brain Barrier Modulation: Advancing Targeted Neurological Therapies
Zahra Razavi,
No information about this author
F. S. Razavi,
No information about this author
Seyed Sina Alizadeh
No information about this author
et al.
European Journal of Medicinal Chemistry,
Journal Year:
2025,
Volume and Issue:
287, P. 117357 - 117357
Published: Feb. 5, 2025
Language: Английский
Advances and applications of hyperthermia in tumor therapy: Mechanisms, techniques, and clinical integration
Cui-Hua Gu,
No information about this author
Jinzhong Zhang,
No information about this author
Jinsong Zeng
No information about this author
et al.
International Communications in Heat and Mass Transfer,
Journal Year:
2025,
Volume and Issue:
164, P. 108895 - 108895
Published: March 29, 2025
Language: Английский
Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword
Sina Kamrani,
No information about this author
Reza Naseramini,
No information about this author
Pouria Khani
No information about this author
et al.
Cancer Cell International,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: March 26, 2025
Abstract
Multiple
myeloma
(MM)
is
a
hematological
malignancy
defined
by
the
abnormal
proliferation
and
accumulation
of
plasma
cells
(PC)
within
bone
marrow
(BM).
While
multiple
impacts
bone,
it
not
classified
as
primary
cancer.
The
microenvironment
significantly
influences
progression
its
treatment
response.
Mesenchymal
stromal
(MSCs)
in
this
environment
engage
with
other
components
via
direct
contact
secretion
soluble
factors.
This
review
examines
established
roles
MSCs
facets
MM
pathology,
encompassing
their
pro-inflammatory
functions,
contributions
to
tumor
epigenetics,
effects
on
immune
checkpoint
inhibitors
(ICIs),
influence
reprogramming,
chemotherapy
resistance,
senescence.
investigates
role
development
MM.
Language: Английский
Current Research in Drug-Free Cancer Therapies
Akshaya Andavar,
No information about this author
Varsha Rajesh Bhagavathi,
No information about this author
J Cousin
No information about this author
et al.
Bioengineering,
Journal Year:
2025,
Volume and Issue:
12(4), P. 341 - 341
Published: March 26, 2025
Cancer
treatment
has
historically
depended
on
conventional
methods
like
chemotherapy,
radiation,
and
surgery;
however,
these
strategies
frequently
present
considerable
limitations,
including
toxicity,
resistance,
negative
impacts
healthy
tissues.
In
addressing
challenges,
drug-free
cancer
therapies
have
developed
as
viable
alternatives,
utilizing
advanced
physical
biological
to
specifically
target
tumor
cells
while
reducing
damage
normal
This
review
examines
several
strategies,
such
high-intensity
focused
energy
beams,
nanosecond
pulsed
electric
fields,
photothermal
therapy
well
the
use
of
inorganic
nanoparticles
promote
selective
apoptosis.
We
also
investigate
significance
targeting
microenvironment,
precision
medicine,
immunotherapy
in
progression
personalized
therapies.
Although
approaches
demonstrate
significant
promise,
challenges
scalability,
safety,
regulatory
obstacles
must
be
resolved
for
clinical
application.
paper
presents
an
overview
current
research
therapies,
emphasizing
recent
advancements,
underlying
scientific
principles,
steps
required
implementation.
Language: Английский